BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27376897)

  • 1. Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
    Girón-Prieto MS; Arias-Santiago S; Del Carmen Cano-García M; Poyatos-Andújar A; de Haro-Muñoz T; Abad-Menor F; Quesada-Charneco M; Arrabal-Polo MÁ; Arrabal-Martín M
    Int Urol Nephrol; 2016 Nov; 48(11):1777-1781. PubMed ID: 27376897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.
    Arrabal-Polo MA; Girón-Prieto MS; Cano-García Mdel C; Poyatos-Andujar A; Quesada-Charneco M; Abad-Menor F; Arias-Santiago S; Zuluaga-Gomez A; Arrabal-Martin M
    Urology; 2015 Apr; 85(4):782-5. PubMed ID: 25817102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of hypercalciuria in patients with osteopenia versus osteoporosis.
    Girón-Prieto MS; Del Carmen Cano-García M; Poyatos-Andújar A; Arias-Santiago S; de Haro-Muñoz T; Arrabal-Martín M; Arrabal-Polo MÁ
    Urolithiasis; 2017 Jun; 45(3):279-283. PubMed ID: 27480097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of severe calcium lithogenic activity and bone remodeling markers.
    Arrabal-Polo MÁ; Arrabal-Martín M; Girón-Prieto MS; Orgaz-Molina J; Quesada-Charneco M; López-Ruiz A; Poyatos-Andujar A; Zuluaga-Gómez A; Arias-Santiago S
    Urology; 2013 Jul; 82(1):16-21. PubMed ID: 23601442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density.
    Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; De Haro-Muñoz TD; Zuluaga-Gomez A
    Singapore Med J; 2012 Dec; 53(12):808-13. PubMed ID: 23268154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.
    Arrabal-Polo MA; Arrabal-Martin M; de Haro-Muñoz T; Poyatos-Andujar A; Palæo-Yago F; Zuluaga-Gomez A
    Urology; 2012 Jan; 79(1):48-54. PubMed ID: 21908029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenia/osteoporosis in patients with calcium nephrolithiasis.
    Arrabal-Polo MA; Arrabal-Martin M; Girón-Prieto MS; Poyatos-Andujar A; Garrido-Gomez J; Zuluaga-Gomez A; Arias-Santiago S
    Urol Res; 2012 Dec; 40(6):709-16. PubMed ID: 22886308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
    Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; Poyatos-Andujar A; Zuluaga-Gomez A
    BJU Int; 2013 Apr; 111(4):622-7. PubMed ID: 22757744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.
    Tastan Y; Kann PH; Tinneberg HR; Hadji P; Müller-Ladner U; Lange U
    Clin Rheumatol; 2016 Nov; 35(11):2789-2795. PubMed ID: 27034172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].
    Giza D; Stompór T; Katra B; Sieradzki J; Sułowicz W
    Przegl Lek; 2001; 58(11):979-84. PubMed ID: 11987839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral density and bone remodelling markers in patients with calcium lithiasis.
    Arrabal-Polo MA; Arrabal-Martin M; de Haro-Munoz T; Lopez-Leon VM; Merino-Salas S; Ochoa-Hortal MA; Garrido-Gomez J; Lahoz-Garcia C; Zuluaga-Gomez A
    BJU Int; 2011 Dec; 108(11):1903-8; discussion 1908. PubMed ID: 21554525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of renal stone formation in patients treated with luteinising hormone-releasing hormone analogues for prostate cancer: importance of bone metabolism and urine calcium.
    Diaz-Convalia E; Arrabal-Polo MA; Cano-Garcia MDC; Dominguez-Amillo A; Canales-Casco N; Arrabal-Martin M
    Int Urol Nephrol; 2018 Mar; 50(3):419-425. PubMed ID: 29374814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.
    Iki M; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2004 Dec; 15(12):981-91. PubMed ID: 15570414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.
    Arrabal-Polo MA; Cano-García Mdel C; Canales BK; Arrabal-Martín M
    Curr Opin Urol; 2014 Nov; 24(6):633-8. PubMed ID: 25188231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.